transglutaminase 2 inhibitors (CHDI Foundation/Evotec)

N/A

Report date: 2025/06/11 10:25:13
NME

Base Information

Drug Nametransglutaminase 2 inhibitors (CHDI Foundation/Evotec)
Drug Alias NameCHDI-00339864CHDI-00316226
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsProtein-glutamine gamma-glutamyltransferase inhibitors
TargetsProtein-glutamine gamma-glutamyltransferase
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChdi Foundation Inc
China Registration ClassN/A

Develop Information

Active CompaniesChdi Foundation IncEvotec SE
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A